2003
DOI: 10.1152/ajpheart.00478.2002
|View full text |Cite
|
Sign up to set email alerts
|

Remodeling of the adventitia during coronary arteriogenesis

Abstract: We studied the role of the adventitia in adaptive arteriogenesis during the phase of active growth of coronary collateral vessels (CV) induced by chronic occlusion of the left circumflex coronary artery in canine hearts. We used electron microscopy and immunoconfocal (IF) labeling for bFGF, matrix metalloproteinase (MMP)-2, MMP-9, tissue-type plasminogen activator (tPA), its inhibitor (PAI-1), fibronectin (FN), and Ki-67. Proliferation of smooth muscle cells and adventitial fibroblasts was evident. Quantitativ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
55
0
1

Year Published

2003
2003
2012
2012

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 82 publications
(59 citation statements)
references
References 26 publications
(33 reference statements)
3
55
0
1
Order By: Relevance
“…Aside from G-CSF, there have been well-investigated substances with arteriogenic efficacy such as monocyte chemoattractant protein-1 23 ; another colony-stimulating factor, granulocytemonocyte CSF (GM-CSF); 24 transforming growth factor ␤1 25 ; fibroblast growth factors 26 ; tumor necrosis factor ␣ 27 ; and matrix metalloproteinases. 28 Among these, only colonystimulating factors have been investigated for clinical use in coronary or peripheral artery disease, whereby GM-CSF has been shown to be effective in the former but not the latter condition. 20,21,29 However, inherent to all the arteriogenic substances is a certain proatherogenic risk because of the shared pathogenic monocyte involvement and inflammation in both processes.…”
Section: Pharmacological Arteriogenesis In Humansmentioning
confidence: 99%
“…Aside from G-CSF, there have been well-investigated substances with arteriogenic efficacy such as monocyte chemoattractant protein-1 23 ; another colony-stimulating factor, granulocytemonocyte CSF (GM-CSF); 24 transforming growth factor ␤1 25 ; fibroblast growth factors 26 ; tumor necrosis factor ␣ 27 ; and matrix metalloproteinases. 28 Among these, only colonystimulating factors have been investigated for clinical use in coronary or peripheral artery disease, whereby GM-CSF has been shown to be effective in the former but not the latter condition. 20,21,29 However, inherent to all the arteriogenic substances is a certain proatherogenic risk because of the shared pathogenic monocyte involvement and inflammation in both processes.…”
Section: Pharmacological Arteriogenesis In Humansmentioning
confidence: 99%
“…In addition to actin and myosin, desmin and calponin are downregulated and fibronectin is upregulated. 82 In general, protein synthesis in SMCs switches to an embryonic pattern.…”
Section: Remodellingmentioning
confidence: 99%
“…41,44,45 Furthermore, matrix metalloproteinase expression is associated with remodeling of the vascular adventitia. 42,46 Characteristics of unstable plaques susceptible to rupture include a large lipid core, a thin fibrous cap, 47 and intraplaque hemorrhage. 48 Matrix metalloproteinases are expressed within atherosclerotic plaques, 49 particularly at the shoulder regions, 50 where increased stresses and matrix degradation may combine to rupture the fibrous cap.…”
Section: Matrix Metalloproteinases and Vascular Pathophysiology: Focumentioning
confidence: 99%